Page last updated: 2024-08-23

nafazatrom and Purpura, Thrombotic Thrombocytopenic

nafazatrom has been researched along with Purpura, Thrombotic Thrombocytopenic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Myatt, L; Williams, HJ; Young, KD1
Durrant, ST; Gordon-Smith, EC; Joosten, P1
Copplestone, JA; Hamblin, TJ; Sadullah, S; Worsley, A1

Other Studies

3 other study(ies) available for nafazatrom and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Thrombotic thrombocytopenic purpura: treatment with nafazatrom.
    Clinical and laboratory haematology, 1984, Volume: 6, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Epoprostenol; Female; Humans; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrazolones

1984
Nafazatrom in treatment of thrombotic thrombocytopenic purpura.
    Lancet (London, England), 1985, Oct-12, Volume: 2, Issue:8459

    Topics: Adult; Drug Therapy, Combination; Epoprostenol; Female; Fibrinolytic Agents; Humans; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrazolones

1985
Nafazatrom in thrombocytopenic purpura.
    Lancet (London, England), 1986, Mar-01, Volume: 1, Issue:8479

    Topics: Adult; Dipyridamole; Female; Humans; Plasma; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrazolones; Recurrence

1986